Identifying critically important vascular access outcomes for trials in haemodialysis: an international survey with patients, caregivers and health professionals
Andrea K. Viecelli(The University of Queensland), Carmel M. Hawley(The University of Queensland), Kevan R. Polkinghorne(Monash Health), Pascal Kopperschmidt(Fresenius Medical Care (Germany)), Jan H.M. Tordoir(Maastricht University Medical Centre), Roberto Pecoits‐Filho(Pontifícia Universidade Católica do Paraná), Allison Tong(The University of Sydney), Jonathan C. Craig(Flinders University), Charmaine E. Lok(University Health Network), David W. Johnson(Hennepin County), Trevor A. Mori(The University of Western Australia), Armando Teixeira‐Pinto(The University of Sydney), Robert R. Quinn(University of Calgary), Ashley Irish, Timmy Lee(University of Alabama at Birmingham), Theodore H. Yuo(University of Pittsburgh), Rob Smith, Tushar J. Vachharajani(Cleveland Clinic), Li Zuo(Wuhan Ship Development & Design Institute), Martin Howell(UNSW Sydney), Raymond Vanholder(Ghent University Hospital), Angela Ju(The University of Sydney), Lai Seong Hooi(Sultanah Aminah Hospital), Emma O’Lone(The University of Sydney), Elaine M. Pascoe(The University of Queensland)
Cited by 44
Related Papers
Clinical practice guideline on diagnosis and treatment of hyponatraemia
|Intensive Care Medicine|2014|1k
Comparison of Risk Prediction Using the CKD-EPI Equation and the MDRD Study Equation for Estimated Glomerular Filtration Rate
|JAMA|2012|991
Cystatin C versus Creatinine in Determining Risk Based on Kidney Function
|New England Journal of Medicine|2013|968
Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy
|The Lancet|2017|923
Editor's Choice – Vascular Access: 2018 Clinical Practice Guidelines of the European Society for Vascular Surgery (ESVS)
|European Journal of Vascular and Endovascular Surgery|2018|829